Expanding the Role of N-of-1 Trials in the Precision Medicine Era: Action Priorities and Practical Considerations
NAM Perspectives · 10.12.2018
DOI: 10.31478/201812d ↗Kurz gefasst
Fachartikel in der Zeitschrift NAM Perspectives, online erschienen am 10.12.2018. Verfasst von Karina W. Davidson und 3 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Heterogeneous responses to the same therapy among individual patients are commonplace in both biomedical research and patient care. Despite being considered by many as the pinnacle of the evidence-based […]
Förderung
- National Institutes of Health
Zitieren
APA
Davidson, K. W., Cheung, Y. K., McGinn, T., & Wang, Y. C. (2018). Expanding the Role of N-of-1 Trials in the Precision Medicine Era: Action Priorities and Practical Considerations. NAM Perspectives. https://doi.org/10.31478/201812d
Vancouver
Davidson KW, Cheung YK, McGinn T, Wang YC. Expanding the Role of N-of-1 Trials in the Precision Medicine Era: Action Priorities and Practical Considerations. NAM Perspectives. 2018. doi:10.31478/201812d
BibTeX
@article{Davidson2018,
author = {Davidson, Karina W. and Cheung, Ying Kuen and McGinn, Thomas and Wang, Y. Claire},
title = {Expanding the Role of N-of-1 Trials in the Precision Medicine Era: Action Priorities and Practical Considerations},
journal = {NAM Perspectives},
year = {2018},
doi = {10.31478/201812d}
}
EUVIMED